![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Aydin Y, Hassa H, Oge T, Yalcin OT, Mutlu FS. 2014. Frequency and determinants of urogenital symptoms in postmenopausal Islamic women. Menopause 21:182–187.
- Baban B, Golubnitschaja O. 2017. The potential relationship between Flammer and Sjögren syndromes: the chime of dysfunction. EPMA Journal 8:333–338.
- Bozkurt N, Ozkan S, Korucuoğlu U, Onan A, Aksakal N, Ilhan M, et al. 2007. Urogenital symptoms of postmenopausal women in Turkey. Menopause 14:150–156.
- Cagnacci A, Venier M, Xholli A, Paglietti C, Caruso S, Study A. 2020. Female sexuality and vaginal health across the menopausal age. Menopause 27:14–19.
- Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. 1989. The epidemiology of serum sex hormones in postmenopausal women. American Journal of Epidemiology 129:1120–1131.
- Crandall C. 2002. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy. Journal of Women's Health 11:857–877.
- Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, et al. 2016. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. American Journal of Obstetrics and Gynecology 215:704–711.
- Goncharenko V, Bubnov R, Polivka J, Jr., Zubor P, Biringer K, Bielik T, et al. 2019. Vaginal dryness: individualised patient profiles, risks and mitigating measures. EPMA Journal 10:73–79.
- Huang AJ, Moore EE, Boyko EJ, Scholes D, Lin F, Vittinghoff E, et al. 2010. Vaginal symptoms in postmenopausal women: self-reported severity, natural history, and risk factors. Menopause 17:121–126.
- Lee KS, Ahn KH. 2019. Artificial neural network analysis of spontaneous preterm labor and birth and its major determinants. Journal of Korean Medical Science 34:e128.
- Nappi RE, Davis SR. 2012. The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI. Climacteric 15:267–274.
- North American Menopause Society. 2007. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause 14:355–369.
- Palma F, Volpe A, Villa P, Cagnacci A, Writing group of AGATA study. 2016. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: the AGATA study. Maturitas 83:40–44.
- Schover LR. 2008. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. Journal of Clinical Oncology 26:753–758.
- Shobeiri F, Jenabi E, Poorolajal J, Hazavehei SM. 2016. The association between body mass index and hot flash in midlife women: a meta-analysis. Journal of Menopausal Medicine 22:14–19.
- Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. 2010. Premature menopause or early menopause: long-term health consequences. Maturitas 65:161–166.
- Thurston RC, El Khoudary SR, Sutton-Tyrrell K, Crandall CJ, Gold E, Sternfeld B, et al. 2011. Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women's Health Across the Nation. Menopause 18:1044–1051.
- van der Stege JG, Groen H, van Zadelhoff SJ, Lambalk CB, Braat DD, van Kasteren YM, et al. 2008. Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure. Menopause 15:23–31.
- van Lunsen RH, Laan E. 2004. Genital vascular responsiveness and sexual feelings in midlife women: psychophysiologic, brain, and genital imaging studies. Menopause 11:741–748.